ELECTROCARDIOGRAPHIC CHANGES AS A PREDICTOR OF CARDIOVASCULAR TOXICITY IN ACUTE TRICYCLIC ANTIDEPRESSANT (AMITRIPTYLINE) OVERDOSE Pavlovski B, Becarovski.

Slides:



Advertisements
Similar presentations
PSYCHOPATHOLOGY.  Developed in the 1960s  Monoamine-oxidase inhibitors (MAOIs)  Increase the amount of Noradrenaline (Norepinephrine) in the synapse.
Advertisements

Discontinuation Syndrome Sue Henderson. Definition Cluster of symptoms that may occur in response to the reduction or cessation of any antidepressant,
Relative toxicity of traditional versus atypical antipsychotics in deliberate self poisoning M A Downes, G K Isbister, D Sibbritt, I M Whyte, A H Dawson.
Drugs on the Brain Emma Robinson RCUK Academic Fellow.
Pharmacology of Antidepressants Dr Andrew P Mallon.
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Relative toxicity of venlafaxine and serotonin specific reuptake inhibitors.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 32 Antidepressants.
Module Three Mood Disorders Lesson 1:What is disorder and how it is manifested Lesson 2: What are the causes of Depression Lesson 3: Which is the treatment.
1 Deaths from antidepressants in England and Wales 1993 to 2000: analysis of a national database of drug-related poisoning deaths Allan Baker, UK Office.
Mood Disorders chapter 12 and 13. What is Bipolar Disorder? (Bipolar #1) Diagnosing and Treating Bipolar Disorder.
Poisoning and Toxicology
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
RELATIVE TOXICITY OF CITALOPRAM AND OTHER SSRIs IN OVERDOSE GK Isbister 1,2, IM Whyte 1,2, AH Dawson 1,2 1 Department of Clinical Toxicology, Newcastle.
Clinical Symptoms of Atrial Fibrillation in Different Ranges of QRS Duration Burda I.Yu., Yabluchansky N.I. Medical Clinics Chair National University of.
Acute Heart Failure in Apical Ballooning Syndrome (Takotsubo/Stress Cardiomyopathy) Clinical Correlates and Mayo Clinic Risk Score Malini Madhavan, MBBS;
Poisoned patient general evaluation:. General approach to poisoned patient. First :Resuscitation and triage. Second: comprehensive evaluation(clinical.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 24 Antidepressant Drugs.
First degree AV block Or PR prolongation. atrioventricular block:, AV block impairment of conduction of cardiac impulses from the atria to the ventricles,
Drugs used in Depression- New groups By Prof. Yieldez Bassiouni.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Oral presentation International Symposium on Pesticides, June 2-6, 1997, Budva, Yugoslavia OUR EXPERIENCE WITH TREATMENT OF ACUTE INTOXICATION BY LANATE.
for MHD & Therapeutics is proud to present And Now Here Is The Host... Insert Name Here.
Case study Which antidepressant Dr. Matthew Miller.
Anti-depressants Dr. Sanjita Das Range Tricyclics Tetracyclics Selective serotonin reuptake inhibitorsSelective serotonin reuptake inhibitors SSRI Serotonin.
Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS)
 Disorders of mood ◦ found throughout history  unipolar or major depression  bipolar or manic depression.
Drugs used in the treatment of affective disorders Dr. Vidumini De Silva.
Indication Contraindication Preparation
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
 : Monoamine hypothesis of depression asserts that depression is caused by functional insufficiency of monoamine neurotransmitter (norepinephrine, serotonin.
INFLUENCE OF UPPER AND LOWER LIMB EXERCISES IN REVIVING BLOOD PRESSURE IN HYPERTENSIVE PATIENTS ANUM HAIDER (BSPT, MSPT, ADPT)
ANTIDEPRESSANTS Drugs which can Elevate Mood (Mood Elevators)
By dr.safeyya alchalabi
Immunology and immunodiagnostics
– р<0.05 between baseline
GLYPICAN-4 LEVELS IN RELATION WITH HORMONAL AND METABOLIC PROFILE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Doç.Dr.Özlem ALTINKAYA.
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
William Eggleston, PharmD1, Nicholas Nacca, MD3, and Jeanna M
Med Chem Tutoring for Antidepressants
Diagnostic characteristics and prognoses of primary-care patients referred for clinical exercise testing: a prospective observational study Nilsson G1,
Introduction to Clinical Pharmacy
Drugs used in Depression- Prof. Yieldez Bassiouni
Predictors of good and poor response in GAD
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Drugs used in Depression- Prof. Yieldez Bassiouni
Systolic Blood Pressure Intervention Trial (SPRINT)
Депресивни состојби во тек на бременост и постнаталниот период
Period 5 Scott Kim Peter Luong
PHARMACOTHERAPY - I PHCY 310
European Heart Association Journal 2007 April
ACUTE SELF-POISONINGS BY VERAPAMIL
National Quality Assessment Evaluating Spironolactone Use During Hospitalization for Acute Myocardial Infarction (AMI) in China: China Patient-centered.
Risk adjustment using administrative and clinical data: model comparison
Giuseppe Biondi Zoccai, MD
Figure legend Serum cholesterol concentration (mg/dL)
Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From.
Division of Cardiovascular Diseases No relevant author disclosures
Predictors of good and poor response in GAD
TCA Poisoning.
Antidepressant drugs.
Tricyclic and Tetracyclic Antidepressants Adverse Effects and Pharmacokinetics In this presentation we discuss adverse effects and pharmacokinetics of.
Drugs used in Depression- Prof. Yieldez Bassiouni
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Correlation between endothelial function and hypertension
Drugs used in Depression-
Tricyclic antidepressant poisoning
Eric S. Berens, MD, Nicholas T. Kouchoukos, MD, Suzan F
Drugs Used in Depression (New group)
Tricyclic antidepressants (TCA)
Poisoning in an intensive care unit: 8 years experience
Presentation transcript:

ELECTROCARDIOGRAPHIC CHANGES AS A PREDICTOR OF CARDIOVASCULAR TOXICITY IN ACUTE TRICYCLIC ANTIDEPRESSANT (AMITRIPTYLINE) OVERDOSE Pavlovski B, Becarovski N, Popovski N, Cibisev A, Trencevska L, Babulovska A Clinic of Toxicology and Urgent Internal Medicine.University Clinical Center. Skopje. Macedonia

BACKGROUND: GENERAL VIEW ON CLINICAL TOXICOLOGY PRACTICE NOWADAYS WORLD TRENDS SLOWLY CHANGES IN PROFIL OF TOXICOLOGICAL CASES

BACKGROUND: NEW ANTIDEPRESSANT DRUGS SSRI (SPECIFIC SEROTONIN REUPTAKE INHIBITORS) AS FLUOXETINE-PROZAC PAROXETINE -SEROXAT FLUVOXAMINE – FEVARIN, FLAXIVRAL SERTRALINE –ASENTRA, ZOLOFT SLOWLY BECOME A PART OF OUR DAILY TOXICOLOGICAL PRACTICE.

AMITRIPTYLINE- (AMYZOL,TRIDEP, ELAVIL, LAROXYL, SAROTEN) STILL REMINDS THE MOST OFTEN USED DRUG IN ACUTE SUICIDAL POISONINGS INVOLVING ALL ANTIDEPRESSANT DRUGS (5-6%) SLOWLY INCREASE

ACCORDING TO PROF.A. MONOV(Clinical Toxicology,Volume, Ist, 1995) REASONS FOR CARDIOVASCULAR TOXICITY DIRECT TOXICITY EFFECT ON M CELLS DIRECT EFFECT ON VASOMOTORES CENTERS DISTURBANCES ON POTASSIUM-NATRIUM ON MIOFIBRILES HYPOVOLEMIA HYPOXEMIA ON MITOHONDRIAL LEVEL DISTURBANSES ON GLYCOGEN SYNTHESIS CORONARY ARTERY SPASM CONDUCTION DISTURBANCES

AMITRIPTYLINE CARDIOTOXICITY MAIN REASONS ANTICHOLINERGIC EFFECT-SINUS TACHYCARDIA SYMPATOMIMETIC EFECT-NORADRENALIN BLOCKADE-POTENTION TACHYCARDIA AND HYPERTENSION AND ARRHYTHMIAS CHINIDIN LIKE EFECT-SLOW M CONTRACTILITY,FREQUENCE AND CORRONARY FLOW

OBJECTIVE: • THE AIM OF THIS STUDY WAS TO EVALUATE: • ELECTROCARDIOGRAPHIC CHANGES • URINE AND SERUM CONCENTRATIONS OF THE DRUG • TO CORRELATE CLINICAL PICTURES IN PATIENTS ACUTELY INTOXICATED BY AMITRIPTYLINE (AMYZOL).

MATERIAL AND METHODS : THE STUDY WAS CARRIED OUT ON FORTY-FOUR CONSECUTIVE PATIENTS 31(71%) WOMEN 13(29%) MEN, ACUTELY INTOXICATED BY AMITRIPTYLINE. PARRTICIPANTS WERE TREATED IN INTENSIVE CARE UNIT DURING THE PAST TWO YEARS

TOTAL NUMBER----------------- 44 WOMEN------------------------------31(71%) MEN-----------------------------------13(29% MEAN AGE--------------------------36,5years (from 18 to 60 years) ATTEMPTS--------------------------ALL

A CORRELATION BETWEEN THE VALUES OF R/aVR, R/SaVR AND QRS INTERVAL GREATER THAN 100miliseconds WERE MADE. SEVERITY OF COMA SCALE(GLAZGOW COMA SCALE) ON ADMISSION WERE EVALUATED FOR EACH PATIENT.ECG, BLOOD PRESSURE AND RESPIRATORY RATE WERE CONTINUALLY MONITORED.

URINE CONCENTRATIONS OF THE DRUG WERE DETERMINED USING THIN LAYER CHROMATOGRAPHY (TLC) AS A SCREENING TEST SERUM CONCENTRATIONS WERE DETERMINED WITH FLUORESCENCE POLARIZATION IMMUNOASSAY TECHNIQUE (FPIA)

RESULTS:GCS FROM THREE TO TWELVE FOR ALL GROUP WERE RANGED. ECG CHANGES: SINUS TACHYCARDIA WAS THE MOST COMMON ADVERSE OUTCOME FOR ALL GROUP.MULTIFOCAL EXTRASYSTOLES, CARDIAC CONDUCTION DISTURBANCES, DIFFERENT DEGREES OF ATRIOVENTRICULAR AND INTRAVENTRICULAR BLOCKS WERE OBSERVED ALSO.SERUM CONCENTRATIONS USING FPIA TECHNIQUE WERE RANGED FROM 232 TO 866/ng/ml.

R/aVR WAS GREATER IN THOSE PATIENTS WHO HAD ARRHYTHMIAS OR SEAZURES THAN IN THOSE WHO DID NOT.SEAZURES OCCURRED IN 6(15%) PATIENTS AND MALIGNANT ARRHYTHMIAS IN 3 (7%) PATIENTS.

STATISTICAL ANALYSES MULTIPLE LOGISTIC REGRESSION ANALYSE: ECG CHANGE :R/aVR of 3 mm of more-SIGNIFICANTLY PREDICTED THESE ADVERSE OUTCOMES

CONCLUSION: ALTHOUGHT THE HISTORY AND PHYSICAL EXAMINATION PLAY AN IMPORTANT ROLE IN THE ASSESSMENT OF PATIENTS WITH TRICYCLIC ANTIDEPRESSANT-AMITRIPTYLINE OVERDOSE, THE PRESENCE OF ANTIHOLINERGIC FEATURES ON EXAMINATION CANNOT PREDICT THE SEVERITY OF THE OVERDOSE.

SEVERAL CLINICAL VARIABLES, IN PARTICULAR ELECTROCARDIOGRAPHIC(ECG) CHANGES, HAVE BEEN PROPOSED AS A GUIDE TO DETERMINE THE SEVERITY OF THE TRICYCLIC ANTIDEPRESSANT POISONINGS. ECG CHANGES ARE VERY PRACTICAL AND USEFUL DATA FOR DIAGNOSTIC AND THERAPEUTIC APPROACH

THERE IS NO CORRELATION BETWEEN URINE, PLASMATIC CONCENTRATIONS AND CLINICAL PICTURES.